When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AGTC - AGTC to update on Phase 2/3 XLRP trial data and Q4 results on September 9
Applied Genetic Technologies Corporation
Applied Genetic Technologies (NASDAQ:AGTC) will provide a management update on its planned Phase 2/3 X-Linked Retinitis Pigmentosa (XLRP) clinical trial design, a re-analysis of dose Groups 2 and 4 data, and new preliminary visual sensitivity data from Group 5 on September 9, 2020.
More news on: Applied Genetic Technologies Corporation, Healthcare stocks news,